SCHEMBL4797183

SCHEMBL4797183

CN1CCN(CCn2cnc(-c3ccccc3)c2-c2cc3c(N)ncnc3s2)CC1.Nc1ncnc2sc(-c3c(-c4ccccc4)ncn3CC=O)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 11/20 0.58
FLT1 P17948 2/20 0.58
KDR P35968 2/20 0.58
ALDH1A1 P00352 6/20 0.43
MAPK1 P28482 2/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
PTGS2 P35354 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4803472 0.93 TEK (0.67) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4803503 0.89 TEK (0.67) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4803703 0.88 TEK (0.64) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4802464 0.84 TEK (0.64) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4803646 0.80 TEK (0.67) TEKFLT1KDRALDH1A1POLB
SCHEMBL4798686 0.79 TEK (0.72) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4802432 0.79 TEK (0.66) TEKFLT1KDRALDH1A1POLB
SCHEMBL4803259 0.79 TEK (0.69) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4804074 0.79 TEK (0.72) TEKFLT1KDRALDH1A1MAPK1
SCHEMBL4801078 0.78 TEK (0.71) TEKFLT1KDRALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7427616-B2 Condensed pyridines and pyrimidines with tie2 (TEK) activity ASTRAZENECA AB (SE) 2008-09-23 US disclosed
EP-1537112-B1 CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY ASTRAZENECA AB (SE) 2006-04-19 EP disclosed
US-20050256140-A1 Condensed pyridines and pyrimidines with tie2 (tek) activity ASTRAZENECA AB (SE) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256140-A1 Condensed pyridines and pyrimidines with tie2 (tek) activity TIE1, TEK, KDR TEK 2/4885FLT1 6/4885KDR 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.